Why Personalized Treatment Effects Matter: Building AI-Assisted Clinical Decision Support with a T-Learner

This document is a self-archived educational monograph published through Zenodo to provide a permanent, citable scholarly record. It has not undergone formal peer review. The content reflects the author's original work on causal machine learning, Clinical Decision Support (CDS), and the practical application of artificial intelligence using synthetic patient data. This archived version corresponds to the technical article originally published on prakashkota.com on July 5, 2026, and has been reformatted as a scholarly monograph for long-term preservation, citation, and academic dissemination. The accompanying web article provides a web-optimized reading experience, while this version serves as the archival record. The concepts presented are demonstrated through a live interactive Clinical Decision Support application available at models.mlpowersai.com. Companion articles and related resources are referenced within the document. Abstract Estimating the average effectiveness of a treatment across a patient population is an important first step in evidence-based medicine. However, physicians treat individual patients rather than populations, and the expected benefit of the same treatment may differ substantially from one patient to another. This article introduces the concept of the Individual Treatment Effect (ITE) and demonstrates how causal machine learning can be used to estimate personalized treatment benefits. Using a synthetic oncology dataset, a T‑learner architecture based on two Random Forest models is developed to estimate the expected clinical outcome under both treated and untreated scenarios for the same patient. The difference between these two predicted outcomes provides an estimate of the patient's individualized treatment benefit and forms the basis of a prototype Clinical Decision Support (CDS) system. The article also discusses model evaluation, interpretation, limitations, and the role of AI in supporting, rather than replacing, physician decision making. Together with Part 1, this article provides a practical introduction to causal inference and individualized treatment-effect estimation for healthcare professionals, engineers, students, and data scientists interested in AI-assisted Clinical Decision Support.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-07-06
DOI
https://doi.org/10.5281/zenodo.21225027
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Why Personalized Treatment Effects Matter: Building AI-Assisted Clinical Decision Support with a T-Learner

Prakash Kota
Zenodo (CERN European Organization for Nuclear Research)
Artificial Intelligence in Healthcare and Education
article

Why Personalized Treatment Effects Matter: Building AI-Assisted Clinical Decision Support with a T-Learner

Prakash Kota
article en

Abstract

This document is a self-archived educational monograph published through Zenodo to provide a permanent, citable scholarly record. It has not undergone formal peer review. The content reflects the author's original work on causal machine learning, Clinical Decision Support (CDS), and the practical application of artificial intelligence using synthetic patient data. This archived version corresponds to the technical article originally published on prakashkota.com on July 5, 2026, and has been reformatted as a scholarly monograph for long-term preservation, citation, and academic dissemination. The accompanying web article provides a web-optimized reading experience, while this version serves as the archival record. The concepts presented are demonstrated through a live interactive Clinical Decision Support application available at models.mlpowersai.com. Companion articles and related resources are referenced within the document. Abstract Estimating the average effectiveness of a treatment across a patient population is an important first step in evidence-based medicine. However, physicians treat individual patients rather than populations, and the expected benefit of the same treatment may differ substantially from one patient to another. This article introduces the concept of the Individual Treatment Effect (ITE) and demonstrates how causal machine learning can be used to estimate personalized treatment benefits. Using a synthetic oncology dataset, a T‑learner architecture based on two Random Forest models is developed to estimate the expected clinical outcome under both treated and untreated scenarios for the same patient. The difference between these two predicted outcomes provides an estimate of the patient's individualized treatment benefit and forms the basis of a prototype Clinical Decision Support (CDS) system. The article also discusses model evaluation, interpretation, limitations, and the role of AI in supporting, rather than replacing, physician decision making. Together with Part 1, this article provides a practical introduction to causal inference and individualized treatment-effect estimation for healthcare professionals, engineers, students, and data scientists interested in AI-assisted Clinical Decision Support.

Zenodo (CERN European Organization for Nuclear Research)
Albany State University (US), University at Albany, State University of New York (US), MPower (Czechia) (CZ)
Quality Education
Openalex Percentile: Top 11%
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.